Cancer Society Says U.S. Report Failed to Prove Health Risks
President’s Cancer Panel called for more public awareness of harm from common chemicals.
Read more on HealthCentral
Cancer Society Says U.S. Report Failed to Prove Health Risks
Dendreon Rises After Winning Approval for Cancer Drug (Update2)
Dendreon Rises After Winning Approval for Cancer Drug (Update2)
April 29 (Bloomberg) — Dendreon Corp. won approval for its first product, a vaccine to fight prostate cancer, after a three-year battle with U.S. regulators. Shares surged the most in a year in New York trading.
Read more on Bloomberg
Related posts
U of L reaches out to rural area in fight with cancer
U of L reaches out to rural area in fight with cancer
After surgery, chemotherapy and radiation, 38-year-old Owensboro, Ky., resident Jennifer Slone is cancer free — and she credits her survival to a gynecological oncologist, a women’s cancer specialist who treated her through a University of Louisville program that reaches out to Western Kentucky.
Read more on Louisville Courier-Journal